Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains

被引:49
作者
Hay, TJ [1 ]
Meek, DW [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
来源
FEBS LETTERS | 2000年 / 478卷 / 1-2期
基金
英国医学研究理事会;
关键词
MDM2; phosphorylation; p53; deletion analysis;
D O I
10.1016/S0014-5793(00)01850-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The MDM2 oncoprotein is a negative regulatory partner of the p53 tumour suppressor. MDM2 mediates ubiquitination of p53 and targets the protein to the cytoplasm for 26S proteosome-dependent degradation. In this paper, we show that MDM2 is modified in cultured cells by multisite phosphorylation. Deletion analysis of MDM2 indicated that the sites of modification fall into two clusters which map respectively within the N-terminal region encompassing the p53 binding domain and nuclear export sequence, and the central acidic domain that mediates p14(ARF) binding, p53 ubiquitination and cytoplasmic shuttling. The data are consistent with potential regulation of MDM2 function by multisite phosphorylation. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 32 条
  • [1] Ashcroft M, 1999, MOL CELL BIOL, V19, P1751
  • [2] Regulation of p53 stability
    Ashcroft, M
    Vousden, KH
    [J]. ONCOGENE, 1999, 18 (53) : 7637 - 7643
  • [3] DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
    Blattner, C
    Tobiasch, E
    Litfen, M
    Rahmsdorf, HJ
    Herrlich, P
    [J]. ONCOGENE, 1999, 18 (09) : 1723 - 1732
  • [4] Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
    Bottger, A
    Bottger, V
    Sparks, A
    Liu, WL
    Howard, SF
    Lane, DP
    [J]. CURRENT BIOLOGY, 1997, 7 (11) : 860 - 869
  • [5] BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110
  • [6] E1A signaling to p53 involves the p19ARF tumor suppressor
    de Stanchina, E
    McCurrach, ME
    Zindy, F
    Shieh, SY
    Ferbeyre, G
    Samuelson, AV
    Prives, C
    Roussel, MF
    Sherr, CJ
    Lowe, SW
    [J]. GENES & DEVELOPMENT, 1998, 12 (15) : 2434 - 2442
  • [7] ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT
    EVAN, GI
    LEWIS, GK
    RAMSAY, G
    BISHOP, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3610 - 3616
  • [8] Functions of the MDM2 oncoprotein
    Freedman, DA
    Wu, L
    Levine, AJ
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) : 96 - 107
  • [9] Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6
    Freedman, DA
    Levine, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) : 7288 - 7293
  • [10] Identification of a CK2 phosphorylation site in mdm2
    Götz, C
    Kartarius, S
    Scholtes, P
    Nastainczyk, W
    Montenarh, M
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (02): : 493 - 501